| Product NDC: | 16590-287 |
| Proprietary Name: | GLIPIZIDE |
| Non Proprietary Name: | GLIPIZIDE |
| Active Ingredient(s): | 10 mg/1 & nbsp; GLIPIZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-287 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074223 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950227 |
| Package NDC: | 16590-287-82 |
| Package Description: | 180 TABLET in 1 BOTTLE (16590-287-82) |
| NDC Code | 16590-287-82 |
| Proprietary Name | GLIPIZIDE |
| Package Description | 180 TABLET in 1 BOTTLE (16590-287-82) |
| Product NDC | 16590-287 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GLIPIZIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19950227 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | GLIPIZIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |